Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study

BACKGROUND: Tocilizumab (TCZ), a humanized monoclonal antibody targeting the interleukin-6 (IL-6) receptor, has been proposed for the treatment of COVID-19 patients; however, limited data are available on the safety and efficacy. METHODS: We performed a retrospective study on severe COVID-19 patient...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Eur J Intern Med
Hauptverfasser: Campochiaro, Corrado, Della-Torre, Emanuel, Cavalli, Giulio, De Luca, Giacomo, Ripa, Marco, Boffini, Nicola, Tomelleri, Alessandro, Baldissera, Elena, Rovere-Querini, Patrizia, Ruggeri, Annalisa, Monti, Giacomo, De Cobelli, Francesco, Zangrillo, Alberto, Tresoldi, Moreno, Castagna, Antonella, Dagna, Lorenzo
Format: Artigo
Sprache:Inglês
Veröffentlicht: European Federation of Internal Medicine. Published by Elsevier B.V. 2020
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7242960/
https://ncbi.nlm.nih.gov/pubmed/32482597
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejim.2020.05.021
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge